Sydney Tang - Concepedia

Author

Sydney Tang

University of Hong Kong ORCID

Also Known As

C SO Tang, D Haithcock, Evangelia Ntounousi, Ka-Fai To, S C W TANG, S C W Tang, S C-W Tang, S CW Tang, S TANG, S Tang

534

Publications

18.6K

Citations

H-Index

198

Concepts

All Affiliations

University of Hong Kong Queen Mary Hospital Chinese University of Hong Kong United Christian Hospital Tung Wah Hospital

About

Sydney Tang is an author at University of Hong Kong specializing in medicine, chronic kidney disease, and nephrology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	40	85	6.9K
2	Public Health	4	4	128
3	Health Sciences	3	3	189
4	Allergy	3	3	76
5	Engineering	2	2	72

Sydney Tang

192

Publications

13.4K

Citations

H-Index

Page 1

	Year	Citations
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases Brad H. Rovin, Sharon G. Adler, Jonathan Barratt, Kidney International Glomerular DiseaseGlomerulonephritisHemodialysisUrologyRenal Disease	2021	2.2K
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases Brad H. Rovin, Sharon G. Adler, Jonathan Barratt, Kidney International	2021	726
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress, The Lancet UrologyRenal DiseaseRenal EventsRenal FunctionDiabetes	2019	589
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference Andrew A. House, Christoph Wanner, Mark J. Sarnak, Kidney International	2019	413
Toll-Like Receptor 4 Promotes Tubular Inflammation in Diabetic Nephropathy Miao Lin, Wai Han Yiu, Hao Wu, Journal of the American Society of Nephrology	2011	371
Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo Sydney Tang, Joseph C.K. Leung, Katsushige Abe, Journal of Clinical Investigation	2003	284
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference Jürgen Floege, Sean Barbour, Daniel Cattran, Kidney International	2019	257
Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference Jennifer E. Flythe, Tara I. Chang, Martin Gallagher, Kidney International	2020	240
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink, The Lancet	2023	224
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers, The Lancet GlomerulonephritisActive-controlled Clinical TrialRenal FunctionKidney FailureChronic Kidney Disease	2023	203

Page 1